SYLVIA LINDSEY: Open Payments
NPI 1265024913 · LAWRENCEBURG, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 26 payments from 12 companies in 2025. Trend: 2023 $340 · 2024 $121 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $97 |
| Amgen Inc. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 1 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| REVANCE THERAPEUTICS, INC. | 1 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
Products named: VRAYLAR, OTEZLA, JARDIANCE, HETLIOZ, DAXXIFY, MOUNJARO, VOQUEZNA, Kerendia.
Industry payments across TN — which companies pay providers there.
